We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$9.7B
AUM Growth
-$152M
Cap. Flow
+$293M
Cap. Flow %
3.03%
Top 10 Hldgs %
29.73%
Holding
234
New
14
Increased
60
Reduced
64
Closed
43

Top Buys

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$74.9M
2
ABT icon
Abbott
ABT
+$45.9M
3
MOH icon
Molina Healthcare
MOH
+$43.5M
4
DHR icon
Danaher
DHR
+$42M
5
MDT icon
Medtronic
MDT
+$38M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$63.1M
2
BAX icon
Baxter International
BAX
+$38.1M
3
CNC icon
Centene
CNC
+$36.2M
4
HOLX
Hologic
HOLX
+$21.4M
5
DXCM icon
DexCom
DXCM
+$16.5M

Sector Composition

Rank Sector Weight
1 Healthcare 97.85%
2 Technology 0.8%
3 Industrials 0.75%
4 Communication Services 0.02%
5 Energy 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAST icon
201
Fastenal
FAST
$54B
-14,000
Closed -$361K
FDS icon
202
Factset
FDS
$9.05B
-1,050
Closed -$415K
GKOS icon
203
Glaukos
GKOS
$9.02B
-143,870
Closed -$6.93M
ICE icon
204
Intercontinental Exchange
ICE
$82.4B
-3,000
Closed -$344K
INGN icon
205
Inogen
INGN
$167M
-242,174
Closed -$10.4M
INTU icon
206
Intuit
INTU
$81.1B
-900
Closed -$486K
IT icon
207
Gartner
IT
$9.41B
-2,100
Closed -$638K
KMX icon
208
CarMax
KMX
$8.27B
-2,850
Closed -$365K
KURA icon
209
Kura Oncology
KURA
$922M
-57,500
Closed -$1.08M
MCO icon
210
Moody's
MCO
$81.7B
-1,250
Closed -$444K
MKC icon
211
McCormick & Company Non-Voting
MKC
$13.4B
-4,000
Closed -$324K
MSCI icon
212
MSCI
MSCI
$40B
-816
Closed -$496K
MTCH icon
213
Match Group
MTCH
$8.84B
-2,378
Closed -$373K
MTD icon
214
Mettler-Toledo International
MTD
$26.8B
-270
Closed -$372K
POOL icon
215
Pool Corp
POOL
$6.7B
-900
Closed -$391K
RVTY icon
216
Revvity
RVTY
$12.3B
-2,200
Closed -$381K
SBUX icon
217
Starbucks
SBUX
$118B
-3,234
Closed -$357K
SCI icon
218
Service Corp International
SCI
$11.4B
-6,500
Closed -$392K
SNY icon
219
Sanofi
SNY
$104B
-67,000
Closed -$3.23M
SPGI icon
220
S&P Global
SPGI
$126B
-1,200
Closed -$510K
ST icon
221
Sensata Technologies
ST
$6.65B
-5,900
Closed -$323K
STZ icon
222
Constellation Brands
STZ
$22.2B
-1,459
Closed -$307K
TCOM icon
223
Trip.com Group
TCOM
$27.5B
-10,000
Closed -$308K
TRMB icon
224
Trimble
TRMB
$12.3B
-4,800
Closed -$395K
TRU icon
225
TransUnion
TRU
$14.8B
-3,696
Closed -$415K

Similar funds

Bellevue Group's Q4 2021 Portfolio in Review

As of Q4 2021, Bellevue Group held 234 positions worth $9.7B, down 1.5% from $9.85B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bellevue Group deployed $293M of net new capital in Q4 2021, opening 14 new positions and adding to 60 existing holdings. Its largest new stake was AstraZeneca: 29,500 shares worth $3.44M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Baxter International, an estimated $38.1M trimmed.

  • Bellevue Group's largest Q4 2021 buy was AstraZeneca: 29,500 shares worth $3.44M.
  • Bellevue Group added most to CareDx in Q4 2021, an estimated $74.9M increase.
  • Bellevue Group's biggest Q4 2021 reduction was Baxter International, cutting an estimated $38.1M.
  • Bellevue Group fully exited HILL-ROM HOLDINGS, INC. in Q4 2021, selling an estimated $63.1M.
  • Bellevue Group's ten largest holdings make up 30% of its $9.7B portfolio in Q4 2021.
  • Bellevue Group opened 14 new positions and closed 43 in Q4 2021.
  • Bellevue Group's portfolio value fell 1.5% quarter-over-quarter to $9.7B.

Based on Bellevue Group's 13F filing for Q4 2021, filed 10 Feb 2022.